Appendix A


Schedule of Data-Gathering

Data Gathering Meeting 1: February 29-March 1, 2012 in Washington, DC

The committee received overview presentations of the CBDP from the following people:

Dr. Gerald Parker, Deputy Assistant Secretary of Defense for Chemical and Biological Defense

Dr. Robert Cohn, Chief Scientist, Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs/Chemical and Biological Defense

BG Lucas Polakowski, Deputy Director for Force Protection and Counter Weapons of Mass Destruction, J8

BG Jess Scarborough, Joint Program Executive Officer for Chemical and Biological Defense

Mr. James Cooke, Deputy Under Secretary of the Army for Test and Evaluation

Mr. Lenny Izzo, Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense

Dr. Alan Rudolph, Director, Chemical and Biological Technologies Directorate, Defense Threat Reduction Agency (DTRA)

In addition to these individuals, the committee heard panel presentations focused on specific capability focus areas. Participants in these panels came from multiple offices from throughout the CBDP enterprise. The



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 105
Appendix A Schedule of Data-Gathering Data Gathering Meeting 1: February 29-March 1, 2012 in Washington, DC The committee received overview presentations of the CBDP from the following people: Dr. Gerald Parker, Deputy Assistant Secretary of Defense for Chemical and Biological Defense Dr. Robert Cohn, Chief Scientist, Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs/Chemical and Biological Defense BG Lucas Polakowski, Deputy Director for Force Protection and Counter Weapons of Mass Destruction, J8 BG Jess Scarborough, Joint Program Executive Officer for Chemical and Biological Defense Mr. James Cooke, Deputy Under Secretary of the Army for Test and Evaluation Mr. Lenny Izzo, Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense Dr. Alan Rudolph, Director, Chemical and Biological Technologies Directorate, Defense Threat Reduction Agency (DTRA) In addition to these individuals, the committee heard panel presenta- tions focused on specific capability focus areas. Participants in these pan- els came from multiple offices from throughout the CBDP enterprise. The 105

OCR for page 105
106 APPENDIX A focus areas were Surveillance, Medical Countermeasures, Enabling Tech- nologies, and Hazard Mitigation. The committee also received a threat assessment briefing. Data Gathering Meeting 2: March 15, 2012 in Dugway, UT A subgroup of the committee visited Dugway Proving Ground in Dugway, UT. The group met with representatives of the facility and heard overview presentations about the site's capabilities and activities. The group also held roundtable discussions with local project managers, senior scientists, and management personnel. The committee toured the Materiel Test Facility, the Combined Chemical Test Facility, the Life Sci- ences Test Facility, and the Joint Ambient Breeze Tunnel. The committee met with the following individuals: COL A. Scott Estes, Commander, DPG SGM Stanley Morton, Jr., Command Sergeant Major, DPG Dr. Kenneth Gritton, Technical Director, WDTC Mr. Ryan Harris, Acting Director, WDTC Mr. Chris Johnson, Chief, WDTC Operations Division Dr. Chris Olson, Chief, WDTC Chemical Test Division Mr. Jeff Garcia, Acting Chief, WDTC Dissemination & Explosives Division Dr. Doug Andersen, Chief, WDTC Life Sciences Division Mr. Ross Rosengren, Chief, Resource Management Mr. Bill Brown, Test Engineering & Integration Division Data Gathering Meeting 3: March 16, 2012 in Natick, MA A subgroup of the committee visited the US Army Natick Soldier Research, Development, and Engineering Center in Natick, MA. The group met with representatives of the facility and heard overview presen- tations about the site's capabilities and activities. The group also partici- pated in a roundtable discussion with principle investigators and senior scientists. The committee toured and met with personnel from the follow- ing programs: Human Factors Lab and Assessment, the Molecular Science & Engineering Team, ARIEM and the Doriot Chambers, and Collective Protection and Shelters. The committee met with individuals, including: Dr. Heidi Gibson, Natick Soldier Research, Development and Engineering Center, Polymer Research Chemist.

OCR for page 105
APPENDIX A 107 Data Gathering Meeting 4: March 19-20, 2012 at Various Locations March 19, Washington, DC The committee heard a number of briefings from representatives from agencies and individuals that have programs relevant to the CBDP initia- tives or capability focus areas. Robert Kadlec, RPK Consulting LLC Randall Long, Director, Chemical and Biological Division, Science and Technology Directorate, Department of Homeland Security Susan Coller-Monarez, Threat Characterization and Attribution Branch Chief, Chemical and Biological Defense Division Science and Technology Directorate, Department of Homeland Security Elizabeth George, Director of the Cooperative Threat Reduction Directorate, Defense Threat Reduction Agency, Department of Defense Carol Linden, Principal Deputy Director, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services Mike Kurilla, Director, Office of BioDefense Research Affairs, National Institute of Allergy and Infectious Diseases, National Institutes of Health Rick Jaffe, Director, Medical Countermeasures, Strategy, and Requirements, Office of Policy and Planning, Health and Human Services Luciana Borio, Assistant Commissioner for Counterterrorism Policy and Director, Office of Counterterrorism and Emerging Threats, Food and Drug Administration March 20, Frederick, MD A subgroup of the committee visited US Army Medical Research Institute for Infectious Diseases (USAMRIID) at Ft. Detrick in Freder- ick, MD. The group met with representatives of the facility and heard overview presentations about the site's capabilities and activities. The committee also toured BSL-2, BSL-4, and ECO facilities and toured the aerobiology laboratory. During the meeting, the group also participated in roundtable discussions with the senior scientists, program managers, and management personnel.

OCR for page 105
108 APPENDIX A The committee met with the following individuals: COL Bernard DeKoning, Commander COL Andrea Stahl, Deputy Commander COL Brian Gentile, Director for Administration SGM Thomas Tuttle, Sergeant Major Dr. Leonard Smith, Acting Science Director Dr. Connie Schmaljohn, Senior Research Scientist Dr. Arthur Friedlander, Supervisory Research Medical Officer Dr. Mark Dertzbaugh, Chief, Business Plans and Programs COL Fernando Guerena, Chief, Division of Medicine LTC Neal Woollen, Director of Safety, Security, and Biosurety Dr. David Norwood, Chief, Diagnostic Systems Division Dr. Jeffrey Teska, NICBR Partnership Office Dr. Aysegul Nalca, Chief, Center for Aerobiological Sciences Dr. Patricia Worsham, Chief, Bacteriology Division Dr. Louise Pitt, Chief, Virology Division Dr. Sina Bavari, Chief, Integrated Toxicology Division Mr. James Coffman, Chief, Office of Research and Technology Applications Ms. Caree Vander Linden, Public Affairs Office COL Randall Rietcheck, Director, Veterinary Medicine Division LTC Pedro Rico, Chief, Pathology Division March 20, Aberdeen, MD A subgroup of the committee visited US Army Medical Research Institute for Chemical Defense (USAMRICD) and Edgewood Chemical Biological Center (ECBC) at Aberdeen Proving Ground in Aberdeen, MD. The group met with representatives, took tours of the facilities, and heard overview presentations about the site's capabilities and activities. At USAMRICD, the committee toured the laboratories and facilities for molecular modeling, chemical surety, behavioral studies, mass spec- trometry and analytical chemistry, and the vivarium. The presentations and tours were led by the following people: COL Peter Schultheiss, Commander COL Deborah Whitmer, Deputy Commander Dr. John Graham, Deputy to the Commander for Research Dr. James Dillman, Chief, Research Program Office Dr. Doug Cerasoli, Program Advisor, Molecular and Cellular Therapeutics

OCR for page 105
APPENDIX A 109 Dr. Lucille Lange, Program Advisor, Toxicologic Modeling LTC Rick Probst, Deputy Chief, Research Support Division Dr. Ben Capacio, Program Advisor, Medical Diagnostics and Forensics Mr. Jonathon Oyler, Chemist, Team Leader for BB Area The committee also met with program advisors and deputy program advisors, division chiefs and deputy division chiefs, and management personnel for a roundtable discussion. At ECBC the committee toured the McNamara Life Science Building, which houses the inhalation chamber, the standoff detection team, the genomics laboratory, and BSL-3 laboratories; the Mobile Laboratory Sys- tems; the Advanced Chemistry Laboratory, which houses Decontamina- tion Science, the Filter Testing Laboratory, and the Synthesis Laboratory; and the Sample Receipt Facility. Following the facility tours, committee members met with the principle investigators for wrap-up discussions then returned to the original meeting room for a roundtable discussion with facility management personnel. The presentations and tours were led by the following people: Dr. Joseph Corriveau, Director, Research and Technology COL Ray Compton, Military Deputy Dr. John Carpin, Biomedical Engineer Dr. Christopher Whalley, (Acting) Division Chief, Toxicology and Obscurants Dr. Mary Wade, (Acting) Branch Chief, BioDefense Mr. Richard Vanderbeek, Branch Chief, Laser Standoff Detection Dr. Sandy Gibbons, Research Microbiologist Dr. Carrie Poore, Team Leader, Advanced CBRNE Training Team Mr. George Noya, Team Leader, Mobile Labs and Kits Team Dr. Teri Lalain, Branch Chief, Decontamination Sciences Dr. Brent Mantooth, Principle Investigator, Modeling Simulation and Analysis Mr. Matt Shue, (Acting) Branch Chief, Decontamination Sciences Dr. Frederick Cox, (Acting) Division Chief, CB Protection and Decontamination Dr. Fred Berg, Division Chief, Chemical Sciences Mr. Chris Druyor, Chemical Engineering Technician Mr. Jerry Pfarr, Microbiologist, Chemical Operations Branch

OCR for page 105
110 APPENDIX A Data Gathering Meeting 5: April 3, 2012 in Washington, DC The committee invited representatives from all of the DOD Combat- ant Commands and the Services to brief the group on their perspectives on the CBD Program and its objectives and capabilities. At its fifth meet- ing, the committee held discussions with representatives from US Euro- pean Command and US Northern Command. The committee also spoke with US DOD Service representatives to the Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear Defense from the US Army and US Marines. Due to unforeseen circumstances, US Strategic Command and the Service representative from the US Air Force were unable to participate. At this meeting, the committee also held roundtable discussions with program managers from the Joint Science Technology Office and the Joint Program Executive Office for Chemical and Biological Defense. The committee was also briefed by Dr. Julie Pavlin, Deputy Director, Armed Forces Health Surveillance Center (AFHSC) and Acting Chief, Global Emerging Infections Surveillance & Response System (GEIS), on GEIS and its activities. Data Gathering Meeting 6: April 18, 2012 in Washington, DC The committee held discussions with representatives from US Spe- cial Operations Command on the CBD Program and its objectives and capabilities.